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Wilms’ Tumor Suppressor Protein C‑terminal Zinc Finger Peptide
Ka Lam Chan,† Inna Bakman,†,‡ Amy R. Marts,§ Yuksel Batir,† Terry L. Dowd,†,‡ David L. Tierney,§
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Ph.D. Program in Biochemistry, The City University of New York, New York, New York 10016, United States
§
Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States
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ABSTRACT: Zinc ﬁnger proteins that bind Zn(II) using a Cys2His2 coordination motif
within a ββα protein fold are the most abundant DNA binding transcription factor
domains in eukaryotic systems. These classic zinc ﬁngers are typically unfolded in the apo
state and spontaneously fold into their functional ββα folds upon incorporation of Zn(II).
These metal-induced protein folding events obscure the free energy cost of protein folding
by coupling the protein folding and metal-ion binding thermodynamics. Herein, we
determine the formation constant of a Cys2His2/ββα zinc ﬁnger domain, the C-terminal
ﬁnger of the Wilms’ tumor suppressor protein (WT1-4), for the purposes of determining
its free energy cost of protein folding. Measurements of individual conditional dissociation
constants, Kd values, at pH values from 5 to 9 were determined using ﬂuorescence
spectroscopy by direct or competition titration. Potentiometric titrations of apo-WT1-4
followed by NMR spectroscopy provided the intrinsic pKa values of the Cys2His2 residues,
and corresponding potentiometric titrations of Zn(II)−WT1-4 followed by ﬂuorescence
spectroscopy yielded the eﬀective pKaeff values of the Cys2His2 ligands bound to Zn(II). The Kd, pKa, and pKaeff values were
combined in a minimal, complete equilibrium model to yield the pH-independent formation constant value for Zn(II)−WT1-4,
KfML value of 7.5 × 1012 M−1, with a limiting Kd value of 133 fM. This shows that Zn(II) binding to the Cys2His2 site in WT1-4
provides at least −17.6 kcal/mol in driving force to fold the protein scaﬀold. A comparison of the conditional dissociation
constants of Zn(II)−WT1-4 to those from the model peptide Zn(II)−GGG−Cys2His2 over the pH range 5.0 to 9.0 and a
comparison of their pH-independent KfML values demonstrates that the free energy cost of protein folding in WT1-4 is less than
+2.1 kcal/mol. These results validate our GGG model system for determining the cost of protein folding in natural zinc ﬁnger
proteins and support the conclusion that the cost of protein folding in most zinc ﬁnger proteins is ≤+4.2 kcal/mol, a value that
pales in comparison to the free energy contribution of Zn(II) binding, −17.6 kcal/mol.

■

INTRODUCTION
Zinc ﬁnger transcription factors are one of the largest classes of
eukaryotic proteins and are characteristic examples of structural
Zn(II) proteins.1 While classically recognized for their DNA/
RNA binding ability,2 zinc ﬁngers are also involved in mediating
protein−protein interactions3 and membrane association4 via
lipid binding and may act as biological redox switches.5 One
key structure−function relationship in zinc ﬁngers is their
metal-induced protein folding events.6 Zinc ﬁngers are typically
unstructured in the apo state, and they fold into their
biologically active ββα fold upon Zn(II) incorporation. The
Zn(II) is bound tightly, sub-nanomolar K d values at
physiological pH, using pseudotetrahedral Cys2His2, Cys3His1,
or Cys4 binding sites.7,8 Because Zn(II) binding and protein
folding are thermodynamically coupled in the metal-induced
protein folding event, the precise free energy contribution of
Zn(II) binding toward protein structure, assembly, and
function is obscured by the underlying free energy cost of
protein folding. Indeed, estimates of the free energy cost of
protein folding in zinc ﬁngers in the literature are as high as +16
kcal/mol.9
© 2014 American Chemical Society

We have developed a method to separate the free energies of
metal-ion binding and protein folding in zinc ﬁnger proteins.10
Our method is based on a designed 16 amino acid peptide
scaﬀold, GGG, into which we individually incorporated each of
the classic zinc ﬁnger metal-ion binding motifs, Cys2His2,
Cys3His1, and Cys4. The resulting three peptides, GGG−
Cys2His2, GGG−Cys3His1, and GGG−Cys4, each bind Zn(II)
in a 1:1 stoichiometry in a pseudotetrahedral coordination
motif with tight aﬃnity, sub-nanomolar K d values at
physiological pH.10,11 A suite of detailed equilibrium measurements over the pH range of 4−9 and a complete description of
the metal−peptide binding equilibrium were used to measure
their formation constant, KfML (or β110) values of 2.5 × 1013, 1.5
× 1015, and 5.6 × 1016 M−1 for GGG−Cys2His2, GGG−
Cys3His1, and GGG−Cys4, respectively.9 The KfML values of
GGG−Cys2His2, GGG−Cys3His1, and GGG−Cys4 indicate
that cysteine thiolates are better ligands than histidine
imidazoles12,13 and that Zn(II) binding is favorable by 18.3,
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20.7, and 22.8 kcal/mol, respectively. Additionally, these KfML
values are attenuated by the ligand pKa values such that the Kd
values at physiological pH are nearly identical, i.e. 1−5 pM.
Because the GGG peptides have no secondary structure in the
apo and holo forms, their free energy cost of protein folding is
minimal and, correspondingly, their Zn(II) binding aﬃnities,
KfML values, are tighter than natural zinc ﬁnger proteins with
the same coordination motif. We10 and others14 have compared
the free energies of Zn(II) binding to the GGG peptide with
the free energy of Zn(II) binding to natural and synthetic zinc
ﬁnger peptides and proteins with the same coordination motif
to deduce the free energy cost of protein folding in the latter at
speciﬁc pH values using conditional dissociation constant
values. These data indicate that the free energy cost of protein
folding in most zinc ﬁngers is between 0−4 kcal/mol.10
However, a recent report by Sénèque and Latour,15 which
reports substantially tighter Zn(II) aﬃnity in the Consensus
Peptide 1 series of designed zinc ﬁngers and slow metal-ion
exchange kinetics, indirectly questions this key result.
To date, our conclusions have been based on comparisons of
conditional dissociation constants between our GGG model
peptide and zinc ﬁngers at individual pH values because of a
lack of KfML values for natural zinc ﬁngers. Herein, we explore
the eﬀect of pH on the free energy cost of protein folding using
a natural Cys2His2 zinc ﬁnger, the C-terminal ﬁnger of the
Wilms’ tumor suppressor protein, 16 WT1-4. We have
determined the formation constant for Zn(II)−WT1-4 to be
7.5 × 1012 M−1 using conditional dissociation constant
measurements, EGTA and HEDTA competition constant
measurements, and potentiometric titrations of the apo and
holo forms. A comparison of the conditional dissociation
constants of Zn(II)−WT1-4 to those from Zn(II)−GGG−
Cys2His2 over the pH range 5.0 to 9.0 and a comparison of the
pH-independent KfML values demonstrate that the free energy
cost of protein folding in both is identical within error. These
results validate our model system and indicate that the pH
eﬀects on the cost of protein folding in peptides with an
unstructured apo form are similar.

■

anaerobic quartz cells of 1.0 cm path length. Peptide concentrations
were determined spectrophotometrically using ε280 of 5600 M−1 cm−1
for Trp.18
Fluorescence Spectroscopy. Excitation and emission ﬂuorescence spectra were recorded on a Cary Eclipse ﬂuorimeter using
anaerobic quartz cells of 1.0 cm path length. Excitation and emission
slit widths of 5.0 and 2.5 nm, respectively, were employed. The
excitation wavelength was 280 nm, and the ﬂuorescence emission was
collected from 300 to 450 nm. Peptide concentrations were between 1
and 25 μM, as determined spectrophotometrically using ε280 = 5600
M−1 cm−1 for Trp.18
NMR Spectroscopy. A 1.2 mM sample of apo-WT1-4 in water
was prepared in an anaerobic glovebox and placed into a NMR tube
equipped with a J. Young valve for spectral measurement. The 600 μL
sample of apo-WT1-4 contained 10 mM KCl, 0.1 mM DSS, and 10%
D2O. The pH was set using microliter aliquots of 0.1 M HNO3 or 0.1
NaOH under strictly anaerobic conditions to prevent cysteine
oxidation.
All 1D and 2D NMR spectra of the apo-WT1-4 peptide were
collected on a Bruker DRX600 NMR spectrometer at 288 K. Water
suppression in all 2D experiments was accomplished with the double
gradient echo methods of Hwang and Shaka.19 The data were
processed using NMRPipe20 and extended using linear prediction and
zero ﬁlling. The data were analyzed using NMRView.21 All proton
resonances for apo-WT1-4 were assigned using the methods
developed by Wüthrich.22 Intraresidue proton resonances were
assigned using both short (15 ms) and long (80 ms) mixing time
TOCSY experiments and a 225 ms mixing time NOESY experiment at
288 K using 640 t1 increments at pH 6.0. The chemical shift values of
the δ and ε protons of His23, His24, and His27 as well as the β protons
of Cys5 and Cys10 were then recorded from long mixing time (80 ms)
TOCSY spectra collected at 17 diﬀerent pH values under strictly
anaerobic conditions.
X-ray Absorption Spectroscopy. Samples of Zn(II)−WT1-4
(∼1−2 mM) were prepared with 20% (v/v) glycerol and loaded in
Lucite cuvettes with 6 μm polypropylene windows before rapid
freezing in liquid nitrogen. X-ray absorption spectra were measured at
the National Synchrotron Light Source (Brookhaven National Lab,
Upton, NY), beamline X3B, with a Si(111) double crystal
monochromator; harmonic rejection was accomplished using a Ni
focusing mirror. Data collection and reduction were accomplished
according to published procedures.23 The data presented for Zn(II)−
WT1-4 represent the average of the six scans.
Both raw and Fourier ﬁltered EXAFS data were ﬁt utilizing
theoretical amplitude and phase functions calculated with FEFF ver.
8.00.24 The Zn−N and Zn−S scale factors and the threshold energy,
ΔE0, were calibrated to the experimental spectra of the tetrakis-1methylimidazole and tetraphenylthiolate complexes of Zn. These
calibrated values (SZn−N = 0.78, SZn−S = 0.85, and DE0 = −16 eV, with
E0 set to 9675 eV) were held ﬁxed in subsequent ﬁts to Zn(II)−WT14 data. First shell ﬁts were then obtained for all reasonable
coordination numbers while allowing the absorber−scatterer distance,
Ras, and the Debye−Waller factor, σas2, to vary. Fits to unﬁltered
EXAFS gave identical results. In no case did inclusion of a mixed ﬁrst
shell, with distinct Zn−N and Zn−O scattering contributions, result in
either a signiﬁcant improvement in ﬁt residual or resolvable Zn−N/
Zn−O distances. Multiple scattering contributions from coordinated
histidines were ﬁt using a set of combined multiple-scattering paths,
according to published procedures.25
Isothermal Titration Fluorimetry: Direct Metal-Ion Titrations. Aqueous stock solutions of Zn(II)Cl2 unbuﬀered at pH 7.0
were added in microliter aliquots to freshly prepared WT1-4 peptide
solutions in aqueous buﬀers under strictly anaerobic conditions in 1.0
cm cuvettes. Samples were allowed to equilibrate for at least 10 min
(at least twice their measured equilibration time) before measurement
of their ﬂuorescence spectra. The conditional metal−ligand dissociation constants, conditional Kd values, were obtained from ﬁtting a
plot of the increase in tryptophan ﬂuorescence at 355 nm against the
[Zn(II)]/[WT1-4] ratio to the following 1:1 equilibrium binding
model.

EXPERIMENTAL SECTION

Materials. Zinc(II) chloride, triﬂuoroacetic acid, ethanedithiol, 1hydroxybenzotriazole, diethyl ether, acetic anhydride, diisopropylethylamine (DIEA), and piperidine were obtained from the Sigma-Aldrich
Chemical Co. Aqueous stock solutions of Zn(II) were quantiﬁed by
atomic absorption spectroscopy. Natural Fmoc-protected amino acids
were obtained from Bachem. HBTU, O-(1H-benzotriazole-1-yl)N,N,N′,N′-tetramethyluronium hexaﬂuorophosphate, was purchased
from Qbiogene. All other chemicals and solvents were reagent grade
and used without further puriﬁcation.
Chemical Synthesis of the Peptide. The 27 amino acid Cterminal zinc ﬁnger peptide of the Wilms tumor suppressor protein17
(WT1-4) was synthesized using sold-phase peptide synthesis.18 The
crude peptide was puriﬁed to homogeneity with HPLC, and the
identity of the puriﬁed peptide was conﬁrmed with mass spectrometry.
The sequence is given below with the zinc-binding residues
highlighted in bold and the tryptophan residue in italics:
WT1‐4

KPFSCRW PSCQKKFARSDELVRHHNMH

UV−vis Spectroscopy. UV−visible spectra were recorded on
either a Varian Cary 100 or a Cary 300 spectrophotometer using
anaerobic quartz cells of 1.0 cm path length. Peptide concentrations
were determined spectrophotometrically using ε280 of 5600 M−1 cm−1
for Trp.18
Circular Dichroism Spectropolarimetry. CD spectra were
recorded on a Aviv Biomedical model 214 CD spectrometer using
6310
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Scheme 1. Equilibrium Model for Zn(II)−WT1-4 Formation

WT1‐4 + {Zn(II)(H 2O)6 }2 + ⇌ Zn(II)−WT1‐4 + 6H 2O

Kd =

(1)

αL =

[{Zn(II)(H 2O)6 }2 +][WT1‐4]
[{Zn(II)−WT1‐4}2 +]

−

+ [H+]4

(3)

where Flmeas, the measured ﬂuorescence emission intensity, is a
function of Fl0, the ﬂuorescence intensity of the WT1-4 peptide ligand
prior to metal binding, Fllim, the limiting emission intensity of the
Zn(II)−WT1-4 complex, MT, the total concentration of metal added
to peptide solution, LT, the total concentration of the WT1-4 peptide,
and Kd, the conditional dissociation constant.
Isothermal Titration Fluorimetry: EGTA and HEDTA Competition Titrations. For pH values above 6.0, conditional equilibrium
dissociation constant determination for the Zn(II)−WT1-4 complex
necessitated the use of EGTA (ethylene glycol tetraacetic acid) and
HEDTA (N-(2-hydroxyethyl)ethylenediamine-N,N′,N′-triacetic acid)
competition.26,27 An unbuﬀered aqueous solution of Zn(II)Cl2 at pH
7.0 was added in microliter aliquots to a buﬀered solution of 22.1 μM
WT1-4 containing 5.0 equiv of competitor (EGTA or HEDTA) under
strictly anaerobic conditions. The increase in ﬂuorescence at 355 nm
upon the addition of Zn(II) was ﬁt to a competition equilibrium
binding model based on eqs 4−8.
EGTA + {Zn(II)(H 2O)6 }2 + ⇌ Zn(II)−EGTA + 6H 2O

(4)

WT1‐4 + {Zn(II)(H 2O)6 }2 + ⇌ Zn(II)−WT1‐4 + 6H 2O

(5)

Kcomp =

KdZn(II) − WT1‐4
KdZn(II) − EGTA

Fl meas = Fl 0 +
⎡
⎣b +

=

[Zn(II)−EGTA][WT1‐4]
[EGTA][Zn(II)−WT1‐4]

δmeas = δ0 +

b = M T − EGTA T − KcompM T − KcompL T

(6)

Fl meas = Fl 0 +
(7)
+

(8)

Where Flmeas, the measured ﬂuorescence emission intensity, is a
function of Fl0, the ﬂuorescence of the WT1-4 peptide prior to metal
binding, Fllim, the limiting ﬂuorescence of the Zn(II)−WT1-4
complex, MT, the total concentration of metal added to peptide
solution, LT, the total concentration of the WT1-4 ligand, EGTAT, the
total concentration of EGTA, and Kcomp, the conditional competition
constant.
The Kcomp value, coupled with the conditional equilibrium
dissociation constant value of Zn(II)−EGTA, KdZn(II)−EGTA, given by
eqs 9−11, gives the conditional equilibrium dissociation constant value
for Zn(II)−WT1-4.

KdZn(II) − EGTA =

(12)

ΔFl1
eff
(−2pH + 2pK a1,2
)

+ 10(−2pH + 2pKa3,4) + 1
ΔFl 2

eff

eff

10

eff

eff

10(−2pH + 2pKa1,2) + 10(−4pH + 2pKa1,2 + 2pKa3,4) + 1

(13)

Where the ﬂuorescence emission at 355 nm measured at any pH,
Flmeas is a function of the initial ﬂuorescence, and Fl0, is the change in
ﬂuorescence due to the ﬁrst and second protonation events, ΔFl1 and
ΔFl2, respectively, the solution pH value, and the eﬀective acid
dissociation constants of the ligands bound to metal, pKa1,2eff and
pKa3,4eff. For Zn(II)−WT1-4, the transition reﬂected by pKa3,4eff
represented ∼65% of the total ﬂuorescence intensity change, with
the remainder represented by the pKa1,2eff-based transition.
pH Dependence of Conditional Dissociation Constants.
Because of the expected proton dependence of the Zn(II)−WT1-4
conditional dissociation constants, Kd values were measured at varying
pH values in order to determine the value of KfML for each metal. The
Kd values of Zn(II)−WT1-4 at each pH were determined as above
using ﬂuorescence spectroscopy. The resulting plots of −log Kd versus

1
K fZn(II) − EGTAαL

Δδ
10(pK a − pH) + 1

where the measured proton chemical shift, δmeas, is a function of
protonated amino acid chemical shift, δ0, the change in chemical shift
due to deprotonation, Δδ, the solution pH value, and the acid
dissociation constant of the amino acid pKa. These four pKa1−4 values
establish the speciation of the apo-WT1-4, as shown in Scheme 1.
Potentiometric pH Titrations. Holo Peptide. Potentiometric
pH titrations of Zn(II)−WT1-4 were performed manually using a 1.0
cm path length ﬂuorescence cuvette ﬁtted with a pH electrode under a
stream of hydrated nitrogen gas. The pH of a 17 μM Zn(II)−WT1-4
sample in unbuﬀered water at pH 10 was adjusted by addition of
microliter aliquots of 0.1 M HCl. Between each addition, the samples
were allowed to equilibrate 3 min prior to measurement of their
ﬂuorescence emission spectra. The pH dependence of the ﬂuorescence
emission at 355 nm was ﬁt to an equation for two separate protonation
events, a cooperative two-proton event with an eﬀective pKa1,2eff value
and a cooperative two-proton event with an eﬀective pKa3,4eff value that
establishes the speciation of Zn(II)−WT1-4 given in Scheme 1.

Fllim − Fl 0
2L T(1 − Kcomp)
⎤
b2 + 4(1 − Kcomp)M TL TKcomp ⎦

(11)

Where αL is the mole fraction of fully deprotonated EGTA,
KfZn(II)−EGTA is the formation constant of fully deprotonated EGTA
for Zn(II), a value of 1013.1, and K(1−4) are the stepwise proton
dissociation constants of EGTA; K1 = 1.0, K2 = 3.1 × 10−2, K3 = 1.0 ×
10−2, and K4 = 2.2 × 10−3.27
Potentiometric pH Titrations. Apo Peptide. The NMR spectra
of WT1-4 support an unfolded apo state because very few
interresidues NOEs were observed and chemical shift values of the
Ha protons were very close to their random coil values.22,28 The pKa
values for the metal-ion ligands in apo-WT1-4 were determined from
ﬁts of the graphs of chemical shift value versus pH for each of the Cys
and His residues using the equation

Fllim − Fl 0 ⎡
(M T + L T + Kd)
2L T ⎣

⎤
(− M T − L T − Kd)2 − (4L TM T) ⎦

(10)

EGTA T = K1K 2K3K4 + K1K 2K3[H+] + K1K 2[H+]2 + K1[H+]3

(2)

The equation used to ﬁt the data is as follows
Fl meas = Fl 0 +

K1K 2K3K4
EGTA T

(9)
6311

dx.doi.org/10.1021/ic500862b | Inorg. Chem. 2014, 53, 6309−6320

Inorganic Chemistry

Article

Figure 1. (Left) Molecular model of the Zn(II)−WT1-4 complex rendered in PyMOL68 and (Right) free energy diagram of zinc ﬁnger protein
folding.
pH is ﬁt to the following equilibrium binding expression for the pHdependent formation of Zn(II)−WT1-4 from the WT1-4 peptide and
{Zn(II)(H2O)6}2+ using the proton binding model in Scheme 1:

of apo-protein folding, ΔGapofolding. There is no direct method to
measure the value of ΔGapofolding, which has been estimated to
be between 0 and +16 kcal/mol.9 The free energy contribution
of metal-ion binding, ΔGML, is the energy diﬀerence between
the apo-folded and holo-folded states; the structure15 is shown
for WT1-4 in Figure 1. ΔGML cannot typically be measured
because of the uncertainty in the value of ΔGapofolding. The
observed free energy contribution of metal-ion binding,
ΔGML−obs, can be directly measured and is weaker than the
free energy contribution of metal-ion binding, ΔGML, by the
free energy cost of protein folding, ΔGapofolding, as follows:

eff
(−2pH + 2pK a1,2
)

((1/K ) × (1 + 10
)/(1 + 10
ML
f

− log Kd = −log

eff

eff

+ 10(−4pH + 2pKa1,2 + 2pKa3,4)

(−pH + pK a1)

+ 10(−2pH + pKa1+ pKa2) + 10(−3pH + pKa1+ pKa2 + pKa3)

)

+ 10(−4pH + pKa1+ pKa2 + pKa3+ pKa4)

(14)

The conditional dissociation constant at any pH, Kd, is a function of
the pH-independent formation constant at high pH, KfML, the eﬀective
acid dissociation constants of the metal-bound histidines, pKa1,2eff, and
cysteines, pKa3,4eff, the acid dissociation constant values for the
histidines, pKa1 and pKa2, and cysteines, pKa3 and pKa4, in the apo
peptide, and the solution pH.

ΔGML = ΔGML − obs + ΔGapo folding

(15)

We have developed a method to tease apart the free energy
of metal-ion binding, ΔGML, from the free energy of protein
folding, ΔGapofolding, in zinc ﬁnger proteins.10 Our method is
based on a designed 16 amino acid peptide scaﬀold, GGG, into
which we individually incorporated each of the classic zinc
ﬁnger metal-ion binding motifs, Cys2His2, Cys3His1, and Cys4.
The resulting three peptides, GGG−Cys 2 His 2 , GGG−
Cys3His1, and GGG−Cys4, each bind Zn(II) in a 1:1
stoichiometry in a pseudotetrahedral coordination motif and
have formation constant values of 2.5 × 1013, 1.5 × 1015, and
5.6 × 1016 M−1, respectively, as determined using a suite of
detailed equilibrium measurements over the pH range of 5−
9.10,11 Because the GGG peptides have no secondary structure
in the apo and holo forms, their free energy cost of protein
folding is minimal, ΔGapofolding = 0 kcal/mol, and their observed
and actual free energy contributions of Zn(II) binding are
equivalent. In natural ZFPs, the observed free energy of Zn(II)
binding is weaker than the actual free energy because of the
positive values of ΔGapofolding. Therefore, the diﬀerence in the
actual free energy of Zn(II) binding to GGG to the observed
free energy of Zn(II) binding to a ZFP can be used to reveal
the cost of protein folding in the ZFP. We and others14 have
compared the free energy of Zn(II) binding to the GGG
peptide to natural and synthetic zinc ﬁnger peptides and

■

RESULTS
Experimental Design. Zinc(II) plays a major role in
biochemistry via its ability to stabilize protein structure.29−36
The largest class of metalloproteins encoded in the human
genome,37,38 the zinc ﬁnger proteins, are typically unstructured
in the absence of Zn(II) and fold into their biologically active
forms upon Zn(II) incorporation.6 Figure 1 shows the Cterminal zinc ﬁnger of the Wilms’ tumor suppressor protein
(WT1-4), which folds into the classic zinc ﬁnger ββα fold upon
binding Zn(II) to its Cys2His2 site.17 Indeed, zinc ﬁnger
proteins are the prototypical examples of metal-induced protein
folding events. Because the free energy of metal-ion binding is
used to overcome the unfavorable free energy of protein
folding, its actual value is obscured in typical measurements of
metal−protein association/dissociation constants.
In zinc ﬁnger proteins (ZFPs) such as WT1-4, the free
energy of Zn(II) binding to the Cys2His2 site is coupled to the
free energy of protein folding.39 Figure 1 shows that the apofolded state is higher in energy than the apo-unfolded state of a
typical zinc ﬁnger, with the diﬀerence equal to the free energy
6312
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proteins with the same coordination motif, derived from
conditional dissociation constant values in the literature, to the
free energy of Zn(II) binding to the GGG peptide with the
same Zn(II) binding motif to determine the free energy cost of
protein folding in the former.
ΔGapo folding ‐ ZFP = ΔGML − obs − ZFP − ΔGML − obs − GGG

(16)

These comparisons indicate that the free energy cost of protein
folding in most zinc ﬁngers is between 0 and +4 kcal/mol, and
it does not appear to vary between the classic coordination
motifs of Cys2His2, Cys3His1, and Cys4 despite the fact that the
KfML values for each motif are distinct.
These conclusions are based on the comparison of the GGG
peptide data to natural and synthetic zinc ﬁnger dissociation
constants at single pH values. Although this has provided
considerable insight into the free energy cost of protein folding
in zinc ﬁngers, the pH dependence of the conditional
dissociation constant values is signiﬁcant, and a comparison
of the pH-independent formation constants, KfML values, is
more accurate because it removes eﬀects resulting from changes
in the His/Cys pKa values. Because of the lack of KfML values
for natural zinc ﬁngers, a comparison of KfML values cannot be
done at this time; in addition, any observed changes in
conditional dissociation constants may reﬂect changes in KfML
values or the inherent His/Cys pKa values. The closest
comparison that can be done is for the Cys3His1 motif based
on amino acids 34−51 of the HIV-1 nucleocapsid protein,
(34−51)NCp7.40,41 The reported KfML value for (34−
51)NCp7 is 2 × 1015 M−1, which is identical, within error, to
the 1.5 × 1015 M−1 value reported for GGG−Cys3His1,
indicating a similar cost of protein folding between these two
peptides. However, any conclusions about zinc ﬁnger protein
folding are somewhat speculative because the Zn knuckle fold
of NCp7 is distinct from the classic zinc ﬁnger ββα fold.
Additionally, the observed similarities in KfML values between
GGG and (34−51)NCp7 may reﬂect their size similarity, 16
versus 18 amino acids, or structural similarity, lack of helical/
sheet structure in the two holo peptides.
Because the literature KfML values for natural zinc ﬁngers do
not exist, we chose to evaluate a classic zinc ﬁnger with
Cys2His2 coordination that adopts the classic ββα fold for this
contribution. A single ﬁnger domain from the full-length four
ﬁnger Wilms’ tumor suppressor protein (WT1) was selected, as
the full-length protein required for kidney and genitourinary
system development42−45 has been structurally characterized by
both NMR and X-ray crystallography.17 The single C-terminal
Cys2His2/ββα ﬁnger zinc ﬁnger, WT1-4, was selected for study
because it is the only one with the intrinsic ﬂuorescence probe
tryptophan in its wild-type sequence. Herein, we present the
ﬁrst intrinsic pH-independent formation constant determination of a natural zinc ﬁnger protein with the classic ββα fold.
The conditional dissociation constants and overall formation
constant for Zn(II)−WT1-4 are determined using a suite of
equilibrium methods that include the measurement of the pKa
and eﬀective pKa values of the His/Cys ligands, which provide a
complete description of the metal−peptide binding equilibrium. These data are used to show that the cost of protein
folding in WT1-4 over the pH range of 5−9 is minimal. These
data validate our method for determining and evaluating the
cost of protein folding across a wide pH range in a natural
protein scaﬀold.

Figure 2. Steady-state ﬂuorescence emission spectra of 22 μM apoWT1-4 (dotted line) and 22 μM Zn(II)−WT1-4 (solid line) in pH 7.0
buﬀer (20 mM HEPES, 100 mM KCl). Each sample was excited
through a 5 nm slit at 280 nm, the tryptophan λmax value, and the
ﬂuorescence emission was collected through a 2.5 nm slit.

Fluorescence Spectroscopy. Figure 2 shows the steadystate ﬂuorescence emission spectrum of WT1-4 and Zn(II)−
WT1-4 at 22 μM concentration in aqueous buﬀer. The
ﬂuorescence emission maximum of Trp7 in apo-WT1-4 at 355
nm indicates that the indole ring is solvent-exposed.46 Zn(II)
binding to WT1-4 results in a slight blue-shift of the emission
maximum to 350 nm, along with an increase in tryptophan
ﬂuorescence emission intensity, which is due, in part, to the
elimination of the quenching mechanism of cysteine thiols.47
The observed hypsochromic shift indicates that Trp7 in the
metal-bound WT1-4 peptide is slightly protected from solvent,
as evidenced in the NMR and X-ray structures of WT1,
whereas Trp7 in apo-WT1-4 is more solvent-exposed.17 These
data are consistent with an unfolded apo-WT1-4 that folds
upon Zn(II) incorporation, and they provide a spectroscopic
indicator of metal-ion binding.
Isothermal Titration Fluorimetry. The intrinsic ﬂuorescence of Trp7 was used to follow the incorporation of Zn(II)
under a variety of solution pH conditions. The conditional
dissociation constants for Zn(II)−WT1-4 were measured over
the pH range of 5.0 to 9.0 using ﬂuorescence spectroscopy
because of the pH dependence on the Kd values resulting from
proton release upon metal-ion binding to apo-WT1-4.
Figure 3 shows the direct titration of Zn(II) into 22 μM
WT1-4 at pH 5.25 (20 mM MES, 100 mM KCl). The
equilibrium binding isotherm shown in Figure 3 is ﬁt to a 1:1
metal−peptide binding model, eq 3, and demonstrates a
conditional dissociation constant value of 22 μM at pH 5.25. At
pH values above 6.0, competition titrations with the chelators
HEDTA and EGTA were performed to obtain accurate
conditional dissociation constant values for Zn(II)−WT1-4.
The formation constants for Zn(II)−HEDTA and Zn(II)−
EGTA and their respective pKa values were used to calculate
their conditional dissociation constants between pH 6.0 and
9.0. Figure 4 shows a typical competition titration of Zn(II)
into a buﬀered pH 9.0 (20 mM Tris, 100 mM KCl) solution
containing 22 μM WT1-4 and 110 μM HEDTA. The
equilibrium binding isotherm shown in Figure 4 is ﬁt to a
competition constant of 3.31. Because the Kd of Zn(II)−
HEDTA is 2.01 × 10−14 M at pH 9.0, the conditional
dissociation constant of Zn(II)−WT1-4 is 6.6 × 10−14 M at pH
9.0. Kinetic experiments were performed to ensure that samples
had reached equilibrium. Figure 5 shows the change in
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Figure 5. Kinetics of Zn(II) removal from 22 μM Zn(II)−WT1-4 by
100 μM EDTA buﬀered at pH 6.65 (20 mM MES, 100 mM KCl)
followed by the decrease in ﬂuorescence emission intensity at 355 nm.
The ﬂuorescence emission intensity drops from an initial value of
145.67 au to 78.45 au in 15 min. Under similar conditions, Sénèque
and Latour15 measured an equilibration time for Zn(II)−CP1-CCHH
of 1600 min.

Figure 3. Direct titration of Zn(II)Cl2 in unbuﬀered aqueous solution
at pH 7.0 into 22 μM WT1-4 buﬀered at pH 5.25 (20 mM HEPES,
100 mM KCl) followed by ﬂuorescence spectroscopy. Spectra are
shown for the addition of 0.00, 0.22, 0.67, 0.99, 1.81, 2.71, 4.07, 6.78,
8.59, and 12.20 equiv of Zn(II) added, with the others were omitted
for clarity. The increase in emission intensity at 355 nm observed upon
Zn(II) binding is ﬁt in the inset to a Zn(II)−WT1-4 conditional
dissociation constant, Kd, value of 9.9 μM at pH 25.

and ﬂuorescence spectroscopies, respectively. The chemical
shifts of apo-WT1-4 were assigned at pH 6.0. The pH
dependence of the Cys and His amino acid chemical shifts was
determined using TOCSY. The pKa values of the liganding
residues were determined by measuring the proton chemical
shifts of Cys5 (Cβ-H), Cys10 (Cβ-H), His23 (Cε1-H, Cδ2-H), and
His27 (Cε1-H, Cδ2-H). Figure 6 shows that plots of proton

Figure 4. Competition titration of Zn(II)Cl2 in unbuﬀered aqueous
solution at pH 7.0 into an aqueous solution containing 22 μM WT1-4
and 110 μM HEDTA buﬀered at pH 9.0 (20 mM Tris, 100 mM KCl)
followed by ﬂuorescence spectroscopy. Spectra are shown for the
addition of 0.00, 0.90, 2.03, 2.94, and 4.29 equiv of Zn(II) added, with
the others omitted for clarity. Under these conditions, a ﬁt to the plot
of ﬂuorescence at 357 nm vs equivalents of Zn(II) added to peptide
using eq 6 gives a competition constant value of 3.31 between WT1-4
and HEDTA. Because the Kd of Zn(II)−HEDTA at pH 9.0 is 20.1 fM,
the resulting Zn(II)−WT1-4 dissociation constant at pH 9.0 is 66.5
fM.

Figure 6. pH titration of the Zn(II) binding residues in WT1-4
followed by NMR spectroscopy. The pH titration curves are ﬁt to
single-proton pKa values of 8.0 (○, Cys5), 7.9 (□, Cys10), 6.2 (■,
His23), and 6.9 (●, His27).

chemical shift versus pH for each resonance were well-ﬁt to
single-proton pKa values, eq 12. The data are ﬁt to pKa values of
8.0, 7.9, 6.2, and 6.9 for Cys5, Cys10, His23, and His27,
respectively (Table 1). These values are close to the solution
values for cysteine and histidine, as expected because of the

ﬂuorescence intensity as a function of time upon addition of 5
equiv of EDTA to 22 μM Zn(II)−WT1-4 in 20 mM MES, 100
mM KCl, at pH 6.65. The initial intensity, 145.67 au, decreases
to 78.45 au in 15 min and remains constant for the following 45
min. Kinetic experiments from direct and competition titrations
shows that all samples were equilibrated within 15 min, so
measurements were taken 30 min after Zn(II) addition to
ensure equilibration.
Potentiometric pH Titrations. The pH-dependent
chemical speciation of WT1-4 in the apo state and with Zn(II)
bound were investigated using pH titrations followed by NMR

Table 1. pKa and pKaeff Values of the Zn(II) Binding
Residues in apo-WT1-4 and Zn(II)−WT1-4
5

Cys
Cys10
His23
His27
6314

pKa

pKaeff

8.0
7.9
6.2
6.9

5.2
5.2
2.6
2.6
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unfolded nature of apo-WT1-4. In addition, these pKa values
establish the apo-peptide speciation in Scheme 1.
The pKaeff values of Zn(II)−WT1-4 were measured using
potentiometric pH titrations followed by ﬂuorescence spectroscopy to determine the appropriate Zn(II) proton
competition equilbrium model. Figure 7 shows that titration

Figure 8. Speciation diagram of the Zn(II)−WT1-4 metal−ligand
complex depicting the diimidazole−dithiolate zinc species (solid line),
Zn(II)−WT1-4, the diimidiazole−dithiol zinc species (dashed line),
Zn(II)−WT1-4−2H+, and the diimidazolium−dithiol species (dotted
line), Zn(II)−WT1-4−4H+. The diagram was generated on the basis
of the protonation behavior of the Zn(II)−WT1-4 complex in Figure
7.
Figure 7. pH titration of 17 μM Zn(II)−WT1-4 followed by
ﬂuorescence spectroscopy. The decrease in tryptophan ﬂuorescence
emission intensity at 355 nm as the pH is lowered by addition of
microliter aliquots of 0.1 N HCl is due to protonation/dissociation of
the Zn(II) bound thiolate/imidazole ligands. The pH titration data is
best ﬁt to an equilibrium model involving two separate protonation
events, a two-proton event with a pKa1,2eff value of 5.2 and a
cooperative two-proton event with a pKa3,4eff value of 2.6.

The slope of the potentiometric curves used to determine the
holo-state pKaeff values show diﬀerent behavior, namely, the
cysteine thiols deprotonate as a pair, and the histidine
imidazoliums deprotonate as a pair. The observed cooperativity
in Cys and His deprotonation results in only three holo-state
species, MLH42+, MLH2, and ML2−, where MLH42+ dissociates
into M(II) and LH4 under the conditions of our experiment.
The speciation observed in the pKa and pKaeff values is used to
derive the expression for the pH dependence of the formation
constant, eq 14. Therefore, measuring both the pKa and pKaeff
values is critical to establishing the speciation model used to
determine the formation constant.
EXAFS Spectroscopy. To verify the coordination sphere of
Zn(II) in complex with WT1-4 further, the k-edge EXAFS of
the metal-bound peptide was examined. As can be seen in
Figure 9 and Table 2, the data are best modeled with a
Cys2His2 coordination sphere. As anticipated, the Zn−S
scattering is substantially stronger than the Zn−N scattering,
and modeling the ﬁrst shell with all low-Z scatterers leads to a
more than 2-fold higher ﬁt residual than a model that contains
only sulfur (compare the ﬁrst two ﬁts in Table 2). The mixed

of 0.1 M HCl into 15 μM Zn(II)−WT1-4 results in a decrease
in tryptophan ﬂuorescence. The pH titration of Zn(II)−WT1-4
is best ﬁt to an equilibrium model involving two distinct twoproton protonation events, a coupled two-proton event at a
pKa1,2eff value of 2.6 and a cooperative two-proton event at a
pKa3,4eff value of 5.2, as shown in Scheme 1. These are assigned
to the protonation of the Zn(II)-bound His residues (2.6) and
Cys (5.2) residues (Table 1), as shown in eqs 17 and 18.
pK a1,2 eff

Zn(II) + WT1‐4−(HisH+)2 (CysH+)2

⇌ Zn(II)−WT1‐4−(His)2 (CysH+)2 + 2H+

pK a3,4 eff

(17)

Zn(II)−WT1‐4−(His)2 (CysH+)2

⇌ Zn(II)−WT1‐4−(His)2 (Cys)2 + 2H+

(18)

pKaeff

The measurement of these eﬀective
values is critical to
providing the correct Zn(II)−H+ competition model for the
equilibrium presented in Scheme 1 and the speciation diagram
for Zn(II)−WT1-4 shown in Figure 8. At pH values greater
than 6.5, Zn(II)−WT1-4 is predominantly in the Cys2His2,
cysteine thiolate/histidine imidazole, form, as shown in Figure
8. Between pH 3.0 and 5.0, the major species is Zn(II)−WT1-4
in the (CysH+)2His2, cysteine thiol/histidine imidazole, form.
Lastly, below pH 2.5, the WT1-4 peptide exists mostly in the
(CysH)2His2, cysteine thiol/histidine imidazolium, form without the metal bound.
Equilibrium Binding Model. The minimal complete
equilibrium binding model for Zn(II)−WT1-4 established by
the measured intrinsic pKa and eﬀective pKaeff values is
presented in Scheme 1. The apo-state pKa values indicated
that each His and Cys ligand individually deprotonates,
resulting in ﬁve species, generically LH4 to L4−, as expected.

Figure 9. EXAFS Fourier transform for Zn(II)−WT1-4 (solid line)
and best ﬁt (open diamonds), modeled as a Cys2His2 coordination
sphere. Inset: Percent improvement (Pi) vs composition plot for
Zn(II)−WT1-4 (open symbols, black line) compared to those for
characterized model peptides (gray lines, as labeled).
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Table 2. EXAFS Curve Fitting Results for Zn(II)−WT1-4a
model
4
4
2
2
2

N
S
S+2S
S+2N
S + 2 N (2 His)

Zn−S

Zn−N

Zn−Hisb

Rfc

Ru

2.85 (18), 3.37 (2.2), 4.17 (10), 4.38 (16)

238
75
61
25
23

420
183
176
128
66

2.07 (6.2)
2.26
2.19
2.28
2.28

(11)
(6.6), 2.32 (5.0)
(2.8)
(2.8)

2.10 (2.4)
2.10 (2.6)

Distances (Å) and disorder parameters (in parentheses, σ2 (10−3 Å2)) shown derive from ﬁts to ﬁltered EXAFS data. Δk = 1.5−13.2 Å−1; ΔR =
0.7−2.3 Å for ﬁrst shell ﬁts; ΔR = 0.1−4.5 Å for multiple scattering ﬁts. bMultiple scattering paths represent combined scattering paths described in
Experimental Section. cGoodness of ﬁt (Rf for ﬁts to ﬁltered data; Ru for ﬁts to unﬁltered data) is deﬁned as 1000 × (∑i N= 1{[Re(χicalc)]2 +
[Im(χicalc)]2})/(∑i N= 1{[Re(χiobs)]2 + [Im(χiobs)]2}), where N is the number of data points.
a

ﬁrst shell of two nitrogen/oxygen and two sulfur donors gives a
nearly 10-fold lower residual than the all nitrogen ﬁt, which is
also one-third that of the all-sulfur model. To better elucidate
the best model for the coordination sphere, a percent
improvement (Pi) versus composition plot (inset in Figure
9), where Pi is deﬁned as Pi = (F2S+2S − Fi)/(F4S) × 100%, was
constructed.48 Comparison of the Zn(II)−WT1-4 ﬁts (black
line) with the curves previously reported for the Zn(II)−
GGG−Cys2His2, Zn(II)−GGG−Cys3His, and Zn(II)−GGG−
Cys4 peptides10 shows that the data for Zn(II)−WT1-4 is most
consistent with that of the Zn(II)−GGG−Cys2His2 peptide.
Multiple scattering ﬁts, which have the lowest ﬁt residual,
further support Zn binding in a Cys2His2 site, with the outer
shell scattering amplitude most consistent with the presence of
two histidyl imidazoles in the primary coordination sphere of
Zn(II). In addition, the distances of Zn−S (2.28 Å) and Zn−N
(2.10 Å) in the 2S+2N (His) model are identical to the one
that are previous reported for Zn(II)−GGG−Cys 2 His 2
peptide10 and are similar to those observed in the NMR
structure of full-length WT1 bound to DNA (Zn−S 2.29/2.30
Å and Zn−N 2.06/2.07 Å; PDB ID: 2JPG 17 ). The
corresponding distances in the X-ray structure of full-length
WT1 bound to DNA (Zn−S 2.44/2.79 Å and Zn−N 2.21/2.29
Å; PDB ID: 2PRT17) are clearly diﬀerent due to the moderate
resolution of the X-ray structure, 3.15 Å. Overall, the EXAFS
analysis indicates that the structure of the bound Zn(II) is the
same in a single-ﬁnger (WT1-4) or the natural four-ﬁnger
(WT1) construct.

proteins from the literature at various pH values to reveal the
cost of protein folding in the latter. These data indicate that
most Cys2His2 zinc ﬁnger proteins possess a minimal cost of
protein folding, <+5 kcal/mol, relative to the −17.6 kcal/mol
contribution of Zn(II) binding. Furthermore, these results
validate our use of the GGG−Cys2His2 model peptide to
deduce the cost of protein folding in natural zinc ﬁnger
proteins.
Scheme 1 shows the minimal complete equilibrium binding
model for Zn(II)−WT1-4 that was established using the
measured intrinsic pKa and eﬀective pKaeff values and used to
determine formation constant value, KfML (β110), of 7.5 × 1012
M−1. Figure 10 shows the conditional association constants of

■

Figure 10. pH dependence of the conditional dissociation constant of
Zn(II) complexation by WT1-4, shown as a plot of the logarithm of
the association constant vs solution pH. The equilibrium binding
model employed to ﬁt the data yields a pH-independent formation
constant, KfML value, of 7.5 × 1012 M−1, or a limiting dissociation
constant of 133 fM, which corresponds to a reaction free energy of
−17.6 kcal mol−1.

DISCUSSION
The formation constant for a natural Cys2His2/ββα zinc ﬁnger
has been determined using a suite of equilibrium measurements
and the minimal complete equilibrium model for metal−
peptide binding. The data describe the metal-ion aﬃnity and
solution speciation of the C-terminal zinc ﬁnger domain in the
Wilms’ tumor suppressor protein, WT1-4, which undergoes a
metal-induced protein folding event. The data demonstrate the
solution speciation of Zn(II)−WT1-4 and indicate a Zn(II)−
WT1-4 formation constant of 7.5 × 1012 M−1, limiting Kd value
of 133 fM, which demonstrates that Zn(II) binding provides up
to 17.6 kcal/mol of free energy to facilitate protein folding and
assembly. These results are identical within error to those of the
GGG−Cys2His2 model peptide,10 formation constant of 2.5 ×
1013 M−1, limiting Kd value of 40 fM, 18.3 kcal/mol, indicating a
similar, minimal cost of protein folding in the two peptides.
The similarity between Zn(II)−WT1-4 and GGG−Cys2His2
extends to their pH-dependent conditional dissociation
constants because of their similar Cys/His pKa and metalbound Cys/His eﬀective pKa values. The conditional Kd values
of Zn(II)−WT1-4 are further compared with other zinc ﬁnger

Zn(II)−WT1-4 as a function of solution pH ﬁt to eq 14
derived from our minimal complete equilibrium model. The
plateau at basic pH yields the Zn(II)−WT1-4 formation
constant value, which is attenuated at pH values below the apostate pKa values because of proton competition for Zn(II)
binding. The slope of the attenuation approaches 4.0, as
expected on the basis of the Cys2His2 coordination sphere, and
plateaus below the pKaeff values to yield the Zn(II)−WT1-44H+ formation constant value, KfMLH4 (β114), of 1.2 M−1. The
complete model allows the independently measured conditional binding constants, pKa and pKaeff values, to be validated
against each other. Notably, the −18.3 kcal/mol free energy
diﬀerence between the intrinsic pKa and eﬀective pKaeff values,
derived from ΔΔG = 2.303RT(∑ pKaeff − ∑ pKa), must be
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Table 3. Cost of Protein Folding in Zn(II)−Cys2His2 Proteins

a

protein

pH

protein Kd
(log Ka)

protein ΔGML‑obs
(kcal/mol)

GGG ΔGML‑obs
(kcal/mol)

ΔGapofolding GGG
(kcal/mol)

WT1-4 ΔGML−obs
(kcal/mol)

ΔGapofolding WT-1
(kcal/mol)

protein
fold

SUP3766
WT1-p50
ZFY49
Ros8751
CP159
CP115
SP1-367
SP1-314
HCCHp56
Ant-F57

6.4
6.5
6.5
6.8
7.0
7.0
7.0
7.4
7.4
7.5

21 nM (7.7)
1.9 nM (8.7)
300 nM (6.5)
36 nM (7.4)
8.5 pM (11.1)
1.2 fM (14.9)
250 pM (9.6)
20 nM (7.7)
54 nM (7.3)
12 nM (7.9)

−10.5
−11.9
−8.9
−10.2
−15.1
−20.3
−13.1
−10.5
−9.9
−10.8

−10.9
−11.2
−11.2
−11.8
−14.0
−14.0
−14.0
−16.3
−16.3
−16.5

+0.4
−0.7
+2.3
+1.6
−1.1
−6.3
+1.0
+5.8
+6.4
+5.7

−12.3
−12.6
−12.6
−13.9
−14.5
−14.5
−14.5
−15.6
−15.6
−15.7

+1.8
+0.7
+3.7
+3.7
−0.6
−5.8
+1.4
+5.1
+5.7
+4.9

ββα
ββα
ββα
βββαα
ββα
ββα
ββα
ββα
NDa
ββα

Not determined.

equivalent within error to the −17.7 kcal/mol free energy
diﬀerence between the MLH42+ and ML2− formation constant
values, derived from ΔΔG = −2.303RT(log KfML − log KfMLH4)
by deﬁnition. This provides a stringent check of the data and a
validation of the equilbrium model used.
The formation constant value, KfML, of 7.5 × 1012 M−1
measured for Zn(II)−WT1-4 is identical within the 10-fold
(1.4 kcal/mol) error to the 2.5 × 1013 M−1 value previously
reported for the Zn(II)−GGG−Cys2His2 model peptide.10 In
each case, Zn(II) binding to the Cys2His2 site contributes about
−18 kcal/mol toward protein folding and metalloprotein
stability. Thus, the KfML data show that the cost of protein
folding in the two peptide scaﬀolds is identical within error, i.e.
ΔGapofolding−WT1‑4 = ΔGapofolding−GGG. Because we assume that
the value of ΔGapofolding−GGG is close to 0 kcal/mol as a result of
the lack of secondary structure in its apo-unfolded and apofolded states, the data indicate that the cost of protein folding in
WT1-4 is also close to 0 kcal/mol. One might expect the longer
sequence of WT1-4 compared to that of GGG to result in a
larger cost of protein folding in the former because of the
greater loss of conformational entropy. However, because the
value of ΔGapofolding−WT1‑4 reﬂects the diﬀerence between the
apo-unfolded and apo-folded states, it encompasses contributions from both favorable and unfavorable changes in enthalpy
(ΔH) and entropy (ΔS). Restriction of the apo-unfolded
ensemble to a structured apo-folded state involves an
unfavorable ΔS term from the loss of conformational entropy
and a favorable ΔH contribution from secondary structure
formation and hydrophobic core packing in the apo-ββα
structure. This situation where the unfavorable contributions to
the folding free energy are oﬀset by favorable terms appears to
be the case also for the Cys3His1 site in the zinc knuckle fold of
HIV-1 nucleocapsid protein (34−51)NCp7.40,41 The KfML
values for (34−51)NCp7 and the corresponding GGG−
Cys3His1 model peptide are 2 × 1015 and 1.5 × 1015 M−1,
respectively, indicating an identical cost of protein folding
between these two peptides and thus a balance between the
favorable and unfavorable free energy terms between the apounfolded state and the apo-folded state. Lastly, a comparison of
the KfML values from these Cys2His2 and Cys3His1 sites
indicates that the Cys3His1site possesses higher aﬃnity,
bolstering our previous conclusion that cysteine thiolate of
Cys is a better ligand than the imidazole of His for Zn(II).10
The similarity in the KfML values of Zn(II)−WT1-4 and
GGG−Cys2His2 does not necessarily indicate equivalent
conditional dissociation constants, Kd values, because of the
inﬂuence of the ligand pKa values, both intrinsic and eﬀective.

In the case of Zn(II)−WT1-4 and GGG−Cys2His2, their Cys/
His pKa values are similar, likely due to the unfolded nature of
their apo states. The similarity in the KfML and the intrinsic
Cys/His pKa values between the two peptides results in similar
Zn(II)−Cys/Zn(II)−His eﬀective pKaeff values, by deﬁnition.
The measured Kd values for Zn(II)−WT1-4 and GGG−
Cys2His2 are all within 1.5 kcal/mol of each other at an
individual pH values. These data indicate that the cost of
protein folding in WT1-4 is also close to 0 kcal/mol over the
pH range 5−9. A close inspection of the data shows a trend in
that at pH values higher than 7.4, GGG−Cys2His2 has up to a
1.0 kcal/mol tighter aﬃnity for Zn(II), whereas Zn(II)−WT1-4
has up to a 1.5 kcal/mol tighter aﬃnity at pH values below 7.0
because of the ligand pKa and pKaeff values. The His pKa values
(6.9/6.5 in GGG vs 6.9/6.2 in WT1-4) and the pKaeff values of
the Zn(II)−Cys residues (5.6 vs 5.4) are nearly identical, but
the Cys pKa values (9.1/8.8 vs 8.0/7.9) and the pKaeff values of
the Zn(II)−His residues (3.2/3.0 vs 2.7) show diﬀerences that
lead to the observed changes in the Kd relative values. The Cys5
and Cys10 pKa values of WT1-4 are likely lower (more acidic)
than those in GGG because of the presence of local cationic
amino acid side chains, Arg6, Lys12, and Lys13. These pKa and
pKaeff changes reﬂect slight diﬀerences in proton management
that eﬀect the conditional dissociation constants while not
aﬀecting the overall formation constant KfML values, which
indicates the importance of determining both the pKa and pKaeff
values.
Table 3 shows the values of the free energy cost of protein
folding, ΔGapofolding, derived for other Cys2His2 zinc proteins
using either the GGG or WT1-4 data sets. The data show that
the cost of protein folding values derived are slightly diﬀerent
depending on whether GGG or WT1-4 Kd values are used. For
example, the ΔGapofolding value of ZFY,49 a Cys2His2/ββα zinc
ﬁnger derived from the human Y-encoded protein, is either
+2.3 or +3.7 kcal/mol at pH 6.5, based on the GGG or WT1-4
data, respectively. Similarly, the cost of folding the third
Cys2His2/ββα zinc ﬁnger of the Wilms’ tumor suppressor
protein, WT1-p,50 is either −0.7 or +0.7 kcal/mol at pH 6.5
based on GGG or WT1-4 data, respectively. The values of
ΔGapofolding change by up to 2.1 kcal/mol (Ros8751 at pH 6.8)
depending on the model data set used and the solution pH, but
this does not alter our prior conclusion that the cost of protein
folding in most Cys2His2 zinc ﬁngers is minimal, ≤ 4.2 kcal/
mol. Our previous conclusion that the cost of protein folding in
most zinc ﬁngers regardless of zinc coordination motif is
minimal is supported by Wilcox’s recent report14 on the
physiological Zn(II) aﬃnity of three natural proteins, Sp1-3,
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conditions used to determine the Zn(II)−CP1-CCHH Kd
values. Sénèque and Latour studied Zn(II) binding using UV
(Zn−S charge transfer band, ε220 = 8700 M−1cm−1) and CD
(protein folding) spectroscopy in phosphate buﬀer in the
presence of the water-soluble reductant TCEP, tris(2carboxyethyl)phosphine, whereas Berg determined the Zn(II)−CP1-CCHH Kd values with UV−vis spectroscopy by
Co(II) competition under strictly anaerobic conditions without
TCEP or phosphate buﬀer. In our own experiments, we
avoided the use of phosphate buﬀer and TCEP because of their
interactions with Zn(II), Zn3[PO4]2 KSP value of 9.0 × 10−33
and TCEP KfML of Zn(II)−TCEP is 813,62 and we utilized
strictly anaerobic conditions. Our measured Kd values for
Zn(II)−WT1-4 and Zn(II)−GGG9 agree with the thermodynamic studies of CP1-CCHH and its variants by Berg and
others.9,60,63,64 Additionally, we observe that the equilibria of
metal-ion binding and metal-ion removal by EDTA are
established within 15 min for both WT1-4 and GGG,
consistent with the metal-ion substitution kinetics of CP1CCHH. Furthermore, our results agree with other thermodynamic studies on natural zinc ﬁngers in the literature, as shown
in Table 3.
While resolution of the diﬀerences observed in Zn(II)−CP1CCHH Kd values is beyond the scope of this report, the
reported KfML (or β110) value may have a signiﬁcant impact on
our method for deducing the cost of protein folding in zinc
ﬁnger peptides and proteins. Sénèque and Latour15 report that
CP1-CCHH binds Zn(II) 13 900-fold, or 5.6 kcal/mol, tighter
than GGG−Cys2His2 and 42 700-fold, or 6.3 kcal/mol, tighter
than WT1-4 based on the KfML values. This ﬁnding suggests
that it costs +5.6 kcal/mol to fold GGG−Cys2His2 and
therefore +5.6 kcal/mol should be added to all of the
ΔGapofolding values derived from GGG−Cys2His2. In order to
validate our approach to determining the cost of protein folding
in Zn(II) proteins further, we are currently determining the
KfML value of human transcription factor IIB (TFIIB), a
Cys3His1 zinc ribbon protein that is folded into the same
structure in both the apo and holo states, as shown by NMR
spectroscopy.65 Thus, we expect the measured KfML value to
reﬂect the zero cost of protein folding in TFIIB.

MyT1-2, and GR-2, which contain the canonical Cys2His2,
Cys3His1, and Cys4 coordination motifs, respectively.
Several other lines of evidence in the literature support these
conclusions. First, the successful redesign of a ββα zinc ﬁnger
to be folded in the apo state did not increase the Zn(II) aﬃnity
dramatically, as would be expected if the cost of protein folding
was large.52,53 Second, molecular dynamics simulations of a zinc
ﬁnger domain suggest that the ensemble of apo-unfolded states
corresponds to the native state in an average sense.54 Third, the
successful computational redesign of a zinc ﬁnger into a stable
ββα fold without the Zn(II) or the ligands indicates that
hydrophobic interactions are suﬃcient to compensate for the
loss of Zn(II) binding.55 Lastly, the MI3 and MI4 proteins,
natural homologues of the prokaryotic Cys2His2/βββαα zinc
ﬁnger protein, Ros87, lack Zn(II) yet achieve the same
functional fold.56
There are at least two examples of zinc ﬁnger proteins with
higher costs of protein folding in the literature, i.e. 6 kcal/mol.
A +5.7 kcal/mol cost of protein folding, based on GGG and
shown in Table 3, is observed for the artiﬁcial “antennaﬁnger”
Ant-F57 at pH 7.5. The observed higher cost of protein folding
is ascribed to the fact that Zn(II) binding induces a
conformational change between two distinct folded states, a
helical apo state and a less helical holo state. Thus, the free
energy associated with Zn(II) binding is used to reorganize the
helical apo-state conformation that is incommensurate with
Zn(II) binding into the holo state. A similar situation may be
observed for HCCHp,58 a Cys2His2 zinc ﬁngerlike peptide from
the HIV-1 virion infectivity factor, which is reported to have
some secondary structure in the apo state. The reported Kd
value of 54 nM at pH 7.4 for HCCHp suggests a + 6.4 kcal/mol
cost of protein folding compared to GGG−Cys2His2.
In our original report, we noted that Berg’s designed
Cys2His2/ββα zinc ﬁnger Consensus Peptide 159,60 (CP1CCHH) possessed a Zn(II) aﬃnity that was slightly tighter
than GGG and therefore had a ΔGapofolding value of −1.3 kcal/
mol, which is within the error of the Kd measurements.
However, a recent report by Sénèque and Latour15 reevaluates
both the zinc aﬃnity of CP1-CCHH and the metal-ion
exchange kinetics, and their ﬁndings diﬀer signiﬁcantly from
Berg’s initial reports. Sénèque and Latour report a KfML (or
β110) value of 3.2 × 1017 M−1 for Zn(II)−CP1-CCHH and a Kd
value at pH 7.0 of 1.25 fM. These values are signiﬁcantly tighter
than our measured Zn(II)−GGG−Cys2His2 and Zn(II)−WT14 values, KfML values of 2.5 × 1013 and 7.5 × 1012 M−1, and our
measured Kd values at pH 7.0 of 56 and 22 pM, respectively, as
well as Berg’s reported Zn(II)−CP1-CCHH Kd value at pH 7.0
of 5.7 pM.55 Sénèque and Latour15 also observe slow metalexchange kinetics (teq > 24 h at pH 6.65) when using EDTA
competition titrations to determine the Kd values of Zn(II)−
CP1-CCHH, whereas we observe rapid kinetics for metal-ion
exchange between Zn(II)−WT1-4 and EDTA (teq < 15 min, at
pH 6.65, shown in Figure 5) and Zn(II)−GGG−Cys2His2 (teq
< 3 min, at pH 6.5), and Berg61 measured rapid displacement of
Co(II) by Zn(II) in CP1-CCHH. Lastly, Sénèque and Latour
observe that Cys to His substitutions yield Zn(II) aﬃnities in
the order CP1-CCCH > CP1-CCCC > CP1-CCHH, whereas
we observe the trend GGG−Cys4 > GGG−Cys3His > GGG−
Cys 2 His 2 . This diﬀerence likely reﬂects the geometic
restrictions imposed by the folded holo state of the CP1
peptides.
The discrepancy between the CP1-CCHH data of Sénèque
and Latour and Berg may reﬂect the diﬀerent experimental

■

CONCLUSIONS
In the present work, we have evaluated the formation constant
for a natural zinc ﬁnger protein domain, the C-terminal zinc
ﬁnger of Wilms’ tumor suppressor, in an eﬀort to validate our
protein folding free energy calculation methodology with a
natural zinc ﬁnger domain over a wide pH range. A comparison
of the formation constants and the condition dissociation
constants at physiological pH demonstrate that the Cys2His2
zinc-binding sites in WT1-4 and GGG have comparable
aﬃnities, within the 1.4 kcal/mol (10-fold) error of the
measurements. This fact leads to the conclusion that the free
energy cost of protein folding in the natural zinc ﬁnger, WT1-4,
and the simple peptide, GGG, is comparable. Furthermore,
given the lack of secondary structure in GGG, we assert that the
free energy cost of protein folding in GGG is close to 0 kcal/
mol. It then follows that the cost of protein folding in WT1-4 is
also close to 0 kcal/mol.
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